PF3D7_1118200

PF3D7_1118200 (PfHsp90) is an essential cytosolic molecular chaperone in Plasmodium falciparum that drives intra-erythrocytic development, with its inhibition arresting parasites at the ring-to-trophozoite transition (PMID:12584193, PMID:15339915). It assembles into ~300 kDa hetero-oligomeric complexes together with PfHsp70 and additional co-chaperones and clients, an assembly disrupted by the Hsp90 inhibitor geldanamycin (PMID:12584193, PMID:15339915). PfHop bridges PfHsp70 and PfHsp90 into a functional complex, with its TPR2A motif preferentially engaging the PfHsp90 C-terminus in a nucleotide-influenced manner (PMID:22005844, PMID:26267894), and PfHsp90 further recruits TPR-domain partners including the phosphatase PfPP5, the immunophilin PfFKBP35, and calcineurin (PMID:11737864, PMID:15850699, PMID:15811524). Biochemically, recombinant PfHsp90 possesses the highest ATPase activity among known Hsp90 proteins (~6-fold above human Hsp90) through a geldanamycin-sensitive N-terminal ATP-binding domain, in which Arg98 confers selectivity for parasite-directed inhibitors, and it additionally harbors a C-terminal nucleotide-binding site (PMID:20837488, PMID:14514358, PMID:22615284, PMID:40907219). Its unusually large charged linker acts as a functional rheostat tuning chaperone activity and co-chaperone interaction, and an acetylation site overlapping the Aha1/p23 binding region modulates complex assembly (PMID:22315411, PMID:20837488). Functionally, PfHsp90 stabilizes the client PfSir2A to maintain histone deacetylase activity and var gene silencing (PMID:36121150), and directly chaperones the active 26S proteasome to sustain proteostasis (PMID:38492573), establishing it as a hub linking chaperone function to gene regulation and protein turnover.

1. 1994 Medium

   Establishing that PfHsp90 is a single-copy, constitutively expressed and heat-inducible gene defined the parasite's core cytosolic chaperone and its unusual charged linker before any functional assay.

   Evidence Gene sequencing, Northern blot, and temperature-upshift analysis of pfhsp86; immunoprecipitation and monkey vaccination challenge

   PMID:7838176 PMID:8303938

   Open questions at the time

   • No protein-level functional or chaperone assay in these studies
   • ATP-binding inferred from sequence rather than measured directly
2. 2001 Medium

   Identifying PfPP5 as a co-immunoprecipitating partner gave the first evidence that PfHsp90 organizes TPR-domain co-chaperones into a native complex.

   Evidence Co-immunoprecipitation of PfPP5 with native PfHsp90 from parasite lysates

   PMID:11737864

   Open questions at the time

   • Single co-IP without reciprocal pulldown
   • No in vitro reconstitution or functional consequence of the interaction
3. 2003 High

   Demonstrating that PfHsp90 forms ~300 kDa PfHsp70-containing complexes and that geldanamycin arrests development answered whether PfHsp90 is functionally essential for the intra-erythrocytic cycle.

   Evidence Sedimentation, SEC, GA inhibition, and flow cytometry in P. falciparum; recombinant ATP-binding assay with GA inhibition and ~20 nM growth IC50

   PMID:12584193 PMID:14514358

   Open questions at the time

   • Client repertoire not defined
   • Genetic (non-pharmacological) essentiality not tested
4. 2004 High

   Showing that the PfHsp90 multi-chaperone complex mediates heat-shock cytoprotection linked the chaperone to temperature-dependent stage progression.

   Evidence Co-IP identifying PfHsp70, PfPP5, tubulin; GA complex disruption and heat-shock flow cytometry

   PMID:15339915

   Open questions at the time

   • Mechanism of client stabilization during heat shock not resolved
   • Role of tubulin association undefined
5. 2005 Medium

   Adding calcineurin and PfFKBP35 as PfHsp90-associated partners expanded the co-chaperone network and rationalized drug synergy with the chaperone.

   Evidence Co-IP from parasite lysates, TPR-domain interaction, and GA/ascomycin/cyclosporin A synergy assays

   PMID:15811524 PMID:15850699

   Open questions at the time

   • Interactions rest on single-method co-IP
   • Functional requirement of each partner for chaperone cycle not established
6. 2010 High

   Quantifying PfHsp90's exceptionally high ATPase activity and mapping an acetylation site over the Aha1/p23 region tied catalytic output and PTM to co-chaperone assembly.

   Evidence In vitro ATPase assay with recombinant full-length protein, MS identification of acetylation, HDAC-inhibitor complex disruption

   PMID:20837488

   Open questions at the time

   • Enzyme responsible for acetylation not identified
   • Physiological trigger for acetylation-dependent dissociation unknown
7. 2012 High

   Chimeric-linker experiments in yeast established the charged linker as a functional rheostat, and SPR plus Arg98 mutagenesis defined the structural basis for parasite-selective ATP-site inhibition.

   Evidence Chimeric yeast Hsp90 constructs with ATPase/biophysical/in vivo assays; SPR harmine binding and Arg98 site-directed mutagenesis

   PMID:22315411 PMID:22615284

   Open questions at the time

   • Endogenous regulators acting on the linker in parasites not identified
   • Selectivity residue validation limited to specific ligands
8. 2015 High

   Domain-resolved PfHop mapping and imidazopyridazine target deconvolution refined how co-chaperones and inhibitors engage distinct PfHsp90 termini.

   Evidence Far Western, SPR, co-IP, split-GFP for PfHop domains; compound target deconvolution to the N-terminal ATP site

   PMID:26267894 PMID:26711771

   Open questions at the time

   • Nucleotide-dependence of PfHop switching not fully mechanistic
   • Downstream clients of these ligand-bound states undefined
9. 2022 High

   Identifying PfSir2A as a stabilized client connected PfHsp90 chaperone activity to histone deacetylation and var gene silencing.

   Evidence Co-IP of PfHsp90-PfSir2A, 17-AAG/Radicicol inhibition, PfSir2A stability/HDAC-activity and var expression readouts

   PMID:36121150

   Open questions at the time

   • Whether stabilization is direct folding or complex-mediated not fully dissected
   • Breadth of PfHsp90-dependent epigenetic clients unknown
10. 2024 High

    Thermal proteome profiling demonstrating PfHsp90-dependent 26S proteasome stability linked the chaperone directly to proteostasis and hydrolytic activity.

    Evidence Thermal proteome profiling, proteasome activity assays, and selective PfHsp90 inhibitors across life stages

    PMID:38492573

    Open questions at the time

    • Structural interface with the 26S proteasome not defined
    • Which proteasome subunits are direct clients unclear
11. 2025 Medium

    Biochemical characterization of a C-terminal nucleotide-binding site added a second, selective nucleotide-interaction module beyond the N-terminal ATPase.

    Evidence Lysine-reactive nucleotide analog affinity, ATP resin, limited proteolysis, and mutagenesis on a C-terminal PfHsp90 truncation

    PMID:40907219

    Open questions at the time

    • Functional role of the C-terminal site in the chaperone cycle not established
    • Single-lab findings with limited mechanistic follow-up

• It remains unresolved how PfHsp90's two nucleotide-binding sites, charged-linker rheostat, and acetylation state are coordinated in vivo to select among its clients (PfSir2A, the 26S proteasome) and co-chaperones during the parasite cycle.
• No integrated structural model of the full PfHsp90 chaperone cycle in P. falciparum
• Complete client census undefined
• Regulatory inputs controlling complex composition unknown